XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Total revenues [1] $ 254,909 $ 303,897 $ 855,162 $ 858,369
Cost of revenue:        
Total cost of revenue 122,807 178,640 440,204 513,736
Marketing expenses 44,509 46,719 182,686 125,470
Selling, general and administrative expenses 26,723 26,958 78,203 83,810
Depreciation and amortization 13,315 9,700 40,997 22,366
Impairment loss 66,198   265,698  
Restructuring and related charges 1,136 281 2,888 4,225
Operating income (loss) (19,779) 41,599 (155,514) 108,762
Interest expense 20,395 23,006 63,294 54,334
Income (loss) before income taxes (40,174) 18,593 (218,808) 54,428
Income tax expense (benefit) 2,243 4,673 (6,795) 18,157
Net income (loss) $ (42,417) $ 13,920 $ (212,013) $ 36,271
Earnings (loss) per share:        
Basic $ (0.87) $ 0.29 $ (4.35) $ 0.79
Diluted [2] $ (0.87) $ 0.29 $ (4.35) $ 0.78
Comprehensive income (loss) $ (39,570) $ 10,081 $ (230,140) $ 20,196
Weighted average common shares and equivalents:        
Basic 48,783 47,923 48,702 45,996
Diluted [2] 48,783 48,584 48,702 46,585
Services        
Revenues:        
Total revenues $ 95,393 $ 159,979 $ 334,941 $ 473,987
Cost of revenue:        
Total cost of revenue 47,511 111,666 194,545 336,581
Products        
Revenues:        
Total revenues 159,516 143,918 520,221 384,382
Cost of revenue:        
Total cost of revenue $ 75,296 $ 66,974 $ 245,659 $ 177,155
[1] The figure for total segments equals the consolidated figure for such item.
[2] The impact of potentially dilutive securities for the three and nine months ended September 30, 2020 was not considered because the impact would be anti-dilutive.